Australia markets closed

Abiomed, Inc. (ABMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
251.88-2.73 (-1.07%)
At close: 4:00PM EDT

Abiomed, Inc.

22 Cherry Hill Drive
Danvers, MA 01923
United States
978 646 1400
http://www.abiomed.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees1,536

Key executives

NameTitlePayExercisedYear born
Mr. Michael R. MinogueChairman, CEO & Pres1.68MN/A1967
Mr. Todd A. TrappCFO & VP800.98kN/A1971
Dr. David M. WeberSr. VP & COO752.48k771.2k1961
Mr. Michael G. HowleyVP & GM of Global Sales522.56kN/A1964
Mr. Andrew J. GreenfieldVP & Chief Commercial Officer547.39kN/A1973
Dr. Thorsten Siess Ph.D.VP & CTON/AN/AN/A
Ms. Ingrid Goldberg WardDirector of Investor RelationsN/AN/AN/A
Mr. Marc A. BeganVP, Gen. Counsel & Sec.N/AN/A1967
Ms. Karen MahoneyHead of Global HRN/AN/AN/A
Dr. Charles A. Simonton M.D.VP & Chief Medical OfficerN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Corporate governance

Abiomed, Inc.’s ISS governance QualityScore as of 31 October 2019 is 10. The pillar scores are Audit: 2; Board: 10; Shareholder rights: 10; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.